SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Xencor (XNCR) -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (29)8/26/2014 4:30:52 PM
From: tuck  Read Replies (3) | Respond to of 136
 
Updated data from an ongoing trial, with further enrollment, hence a bit more robustness. The fly in KITE's ointment, of course, is the tox. Perhaps in the publication they'll talk about the grades of the AE's (i.e. the severity). I have to grant that there is some differentiation on the safety/efficacy spectrum, but it seems to me XNCR's program is on the same line on that plot, so to speak.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News